Intralesional corticosteroid injections in the treatment of central giant cell lesions of the jaws
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
11/12/2013
11/12/2013
01/03/2013
|
Resumo |
Objective: The aim of this study was to evaluate the response of treatment of central giant cell lesion to intralesional corticosteroid injections. Study Design: Review of articles indexed in PubMed on the topic between the years 1988 and 2011, and development of a descriptive meta-analysis of the results. Results: Sample of 41 patients primarily treated with intralesional corticosteroid injections was obtained, with a male female ratio of 1:0.95, being 23 aggressive and 18 non-aggressive central giant cell lesions. Triamcinolone acetonide and triamcinolone hexacetonide were the drugs used, and 78.0% cases were considered as good result, 14.6% were considered as moderate response and 7.3% were considered as negative result to treatment. Considering the aggressiveness, 88.9% of non-aggressive lesions presented a good response to treatment, in aggressive central giant cell lesions, 69.6% presented a good response to intralesional corticosteroid injections. Conclusion: In view of the results analyzed, intralesional corticosteroid injections could be considered as first treatment option for central giant cell lesion. |
Identificador |
Medicina Oral Patologia Oral y Cirugia Bucal, Valencia, v. 18, n. 2, p. e226-e232, Mar. 2013 1698-4447 http://www.producao.usp.br/handle/BDPI/43585 10.4317/medoral.18245 |
Idioma(s) |
eng |
Publicador |
Sociedad Española de Medicina Oral Valencia |
Relação |
Medicina Oral Patologia Oral y Cirugia Bucal |
Direitos |
openAccess Sociedad Española de Medicina Oral |
Palavras-Chave | #Central giant cell lesion #corticosteroids injections #triamcinolone hexacetonide #triamcinolone acetonide #GRANULOMA DE CÉLULAS GIGANTES #MAXILAR |
Tipo |
article review article publishedVersion |